The safety and efficacy of ranitidine bismuth citrate in combination with antibiotics for the eradication of Helicobacter pylori

Alimentary Pharmacology and Therapeutics

Volumn 10, Issue 4, 1996, Pages 623-630

  Wyeth, J W ^a   Pounder, R E ^a   Duggan, A E ^b   O'Morain, C A ^c   Schaufelberger, H D ^d   De Koster, E H ^e   Rauws, E A J ^f   Bardhan, K D ^g   Gilvarry, J ^c   Buckley, M J M ^c   Gummett, P A ^d   Logan, R P H ^d  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c ADELAIDE AND MEATH HOSPITAL   (Ireland)

^d CENTRAL MIDDLESEX HOSPITAL   (United Kingdom)

^e BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

^g ROTHERHAM GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFUROXIME AXETIL; CLARITHROMYCIN; METRONIDAZOLE; RANITIDINE BISMUTH CITRATE; TETRACYCLINE;

ADULT; ARTICLE; BACTERIAL INFECTION; BREATH ANALYSIS; DIARRHEA; DRUG EFFICACY; DRUG RESISTANCE; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; ENDOSCOPY; HEADACHE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VOMITING;

EID: 9344249066     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1996.46188000.x     Document Type: Article

References (14)

1. Chiba N, Rao BV, Rademaker JW, Hunt RH. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol 1992; 87: 1716-27.
2. Dixon JS. Helicobacter pylori eradication: unravelling the facts. Scand J Gastroenterol 1945; 30 (Suppl. 212): 48-62.
3. Tytgat GNJ. Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment Pharmacol Ther 1994; 8: 359-68.
4. Penston JG. Review article: Helicobacter pylori eradication - understandable caution but no excuse for inertia. Aliment Pharmacol Ther 1994; 8: 369-90.
5. 2 antagonist. Dig Dis Sci 1991; 36: 25-8.
6. Stables R, Campbell CJ, Clayton NM, et al. Gastric anti-secretory, mucosal protective, anti-pepsin and anti-Helicobacter properties of ranitidine bismuth citrate. Aliment Pharmacol Ther 1993; 7: 237-46.
7. McLaren A, McColm AA, McDowell SR, Bagshaw JA. Ranitidine bismuth citrate (GR122311X): a novel compound with superior anti-Helicobacter activity to a mixture of ranitidine and bismuth citrate. Am J Gastroenterol 1994; 89: 1381.
8. Logan RPH, Gummett PA, Misiewicz JJ, et al. The efficacy of ranitidine bismuth citrate (GR 122311X) in the treatment of Helicobacter pylori infection. Gastroenterology 1992; 102 (4, part 2): A114.
9. Bardhan KD, Dekkers CPM, Lam SK, et al. GR122311X (ranitidine bismuth citrate) a new drug for the treatment of duodenal ulcer. Aliment Pharmacol Ther 1995; 9: 497-506.
10. 2-receptor antagonist activity, on 24-hour intragastric acidity. Aliment Pharmacol Ther 1991; 5: 481-90.
11. 13C-urea breath test for the detection of Helicobacter pylori. Eur J Gastroenterol Hepatol 1991; 3: 915-21.
12. Zeeghers J, Jonckheere J. Bismuth determination by atomic absorption spectrometry (AAS): Validation report in biological samples. In press.
13. McLaren A, McDowell SR. GR122311X can significantly reduce the emergence of H. pylori strains resistant to antibiotics. Gut 1995; 57 (Suppl. 1): A62.
14. Webb DD, Ciociola AA, Perschy TB, Goodwin BB. Effect of ranitidine bismuth citrate with food on the suppression and eradication of Helicobacter pylori infected volunteers. Am J Gastroenterol 1995; 90: 1273-7.